- Home
- SABS vs BFRG Comparison
SABS vs BFRG Comparison
Compare SABS & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- BFRG
- Stock Information
- Founded
- SABS 2014
- BFRG 2017
- Country
- SABS United States
- BFRG United States
- Employees
- SABS N/A
- BFRG N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- BFRG Retail: Computer Software & Peripheral Equipment
- Sector
- SABS Health Care
- BFRG Technology
- Exchange
- SABS Nasdaq
- BFRG Nasdaq
- Market Cap
- SABS 15.8M
- BFRG 16.4M
- IPO Year
- SABS N/A
- BFRG 2023
- Fundamental
- Price
- SABS $1.76
- BFRG $1.56
- Analyst Decision
- SABS Strong Buy
- BFRG
- Analyst Count
- SABS 5
- BFRG 0
- Target Price
- SABS $11.80
- BFRG N/A
- AVG Volume (30 Days)
- SABS 17.6K
- BFRG 150.4K
- Earning Date
- SABS 08-07-2025
- BFRG 08-06-2025
- Dividend Yield
- SABS N/A
- BFRG N/A
- EPS Growth
- SABS N/A
- BFRG N/A
- EPS
- SABS N/A
- BFRG N/A
- Revenue
- SABS $377,835.00
- BFRG N/A
- Revenue This Year
- SABS N/A
- BFRG N/A
- Revenue Next Year
- SABS N/A
- BFRG N/A
- P/E Ratio
- SABS N/A
- BFRG N/A
- Revenue Growth
- SABS N/A
- BFRG N/A
- 52 Week Low
- SABS $1.00
- BFRG $1.23
- 52 Week High
- SABS $5.01
- BFRG $4.84
- Technical
- Relative Strength Index (RSI)
- SABS 48.13
- BFRG 38.12
- Support Level
- SABS $1.69
- BFRG $1.48
- Resistance Level
- SABS $1.87
- BFRG $1.67
- Average True Range (ATR)
- SABS 0.11
- BFRG 0.11
- MACD
- SABS -0.01
- BFRG -0.02
- Stochastic Oscillator
- SABS 53.45
- BFRG 6.54
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.